scholarly journals A complementary and alternative natural antidepressant therapy with emphasis on their mechanisms of action

Author(s):  
Ali Esmail Al-Snafi

Medicinal plants can exert antidepressant activity by many mechanisms included neutralization of various stress mediators (regulate the activity of the hypothalamic- pituitary- adrenal axis and reduce CRF, and ACTH and corticosterone) [5], interaction with serotonergic systems (5-HT3, 5HT2A, 5-HT1A), noradrenergic (α1 and α2 receptors) and dopaminergic (D1 and D2) receptors [6],restoring monoamine transmitters and their receptors to normal limits in certain regions of the cortex, in addition to reducing of oxidative stress and amelioration of inflammatory mediators. The current review discussed the antidepressant activity of medicinal plants, with emphasis on their mechanisms of action.

2021 ◽  
Vol 17 (3) ◽  
pp. 061-077
Author(s):  
Ali Esmail Al-Snafi

Insomnia and anxiety are worldwide medical problems. Plant extracts possessed sedative and anxiolytic effect via different mechanisms included interactions with Na+ channels, γ-aminobutyric acid type A receptors, N-methyl-D-aspartate receptors and chatecholamines. In the current review, Web Science, PubMed, Scopus and Science Direct, were searched to investigate the plants with sedative and anxiolytic effects


2015 ◽  
Vol 26 (3) ◽  
Author(s):  
Marzieh Sarbandi Farahani ◽  
Roodabeh Bahramsoltani ◽  
Mohammad Hosein Farzaei ◽  
Mohammad Abdollahi ◽  
Roja Rahimi

AbstractDepression is a serious widespread psychiatric disorder that affects approximately 17% of people all over the world. Exploring the neurological mechanisms of the antidepressant activity of plant-derived agents could have a crucial role in developing natural drugs for the management of depression. The aim of the present study is to review the neurological mechanisms of action of antidepressant plants and their constituents. For this purpose, electronic databases, including PubMed, Science Direct, Scopus, and Cochrane Library, were searched from 1966 to October 2013. The results showed that several molecular mechanisms could be proposed for the antidepressant activity of medicinal plants and their constituents.


1990 ◽  
Vol 186 (2-3) ◽  
pp. 223-230 ◽  
Author(s):  
Sanders A. McDougall ◽  
Timothy F. Arnold ◽  
Arthur J. Nonneman

2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Qing Ye ◽  
Xiao-Lei Yuan ◽  
Jie Zhou ◽  
Can-xing Yuan ◽  
Xu-ming Yang

This study was performed to observe the effects of Zishenpingchan granule on neurobehavioral manifestations and the activity and gene expression of striatal dopamine D1 and D2 receptors of rats with levodopa-induced dyskinesias (LID). We established normal control group, LID model group, and TCM intervention group. Each group received treatment for 4 weeks. Artificial neural network (ANN) was applied to excavate the main factor influencing variation in neurobehavioral manifestations of rats with LID. The results showed that overactivation in direct pathway mediated by dopamine D1 receptor and overinhibition in indirect pathway mediated by dopamine D2 receptor may be the main mechanism of LID. TCM increased the efficacy time of LD to ameliorate LID symptoms effectively mainly by upregulating dopamine D2 receptor gene expression.


2001 ◽  
Vol 69 (3-4) ◽  
pp. 409-418 ◽  
Author(s):  
Keith M Erikson ◽  
Byron C Jones ◽  
Ellen J Hess ◽  
Qian Zhang ◽  
John L Beard

1995 ◽  
Vol 269 (4) ◽  
pp. R896-R903 ◽  
Author(s):  
I. Bednar ◽  
H. Carrer ◽  
G. A. Qureshi ◽  
P. Sodersten

A dopamine D1 (SKF-38393, 1 mg)- or D2 (LY-171555, 0.1 mg)-receptor agonist inhibited intake of an intraorally infused solution of sucrose by male rats, a test of consummatory ingestive behavior. Treatment with a D1 (SCH-39166, 0.1 mg) or D2 (raclopride, 0.6 mg) antagonist reversed inhibition by the respective agonist but enhanced the inhibitory effect of cholecystokinin octapeptide (CCK-8; 1.8 micrograms). It was not possible to demonstrate specific effects of D1 and D2 agonists on intake of pellets, a test that does not discriminate consummatory ingestive behavior from appetitive ingestive behavior, i.e., behavior used to obtain food. The results demonstrate specific involvement of dopamine D1 and D2 receptors in inhibition of consummatory ingestive behavior.


1993 ◽  
Vol 32 (6) ◽  
pp. 515-517 ◽  
Author(s):  
P NEEDHAM ◽  
M SKILL ◽  
A COWAN ◽  
R REDFERN ◽  
D HEAL

1994 ◽  
Vol 14 (10) ◽  
pp. 6144-6152 ◽  
Author(s):  
MS Hooks ◽  
JL Juncos ◽  
JB Justice ◽  
SM Meiergerd ◽  
SL Povlock ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document